Efficacy of Gamification in Enhancing User Engagement in Visual Mapping Assistive Technology
MapHabit, Inc. is exploring the efficacy of gamification in its assistive technology aimed at individuals with mild to moderate Alzheimer's disease and related dementias. The market for dementia care technologies is expanding, driven by an increasing aging population and a growing need for innovative solutions to improve patient engagement and caregiver support. The competitive landscape includes various digital health solutions targeting dementia care, but few incorporate gamification as a core feature. Successful outcomes from this trial could position MapHabit favorably in the market, potentially leading to partnerships or acquisition interest from larger healthcare companies. Diligence should focus on the scalability of the technology and the regulatory landscape, given that the MapHabit system is not classified as a regulated medical device.
Indication: Alzheimer Disease
Modality: medical device
Target: Gamification features in assistive technology for enhancing user engagement and quality of life in individuals with Alzheimer's disease and related dementias.
Sponsor: MapHabit, Inc.
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 11, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Gamification features in assistive technology for enhancing user engagement and quality of life in individuals with Alzheimer's disease and related dementias.
View original source fields
Condition raw: Alzheimer Disease, Dementia, Gamification, Assistive Technology
Condition normalized: Alzheimer Disease, Dementia, Gamification, Assistive Technology
Modality raw: medical device
Modality normalized: medical device
Target raw: Gamification features in assistive technology for enhancing user engagement and quality of life in individuals with Alzheimer's disease and related dementias.
Target normalized: Gamification features in assistive technology for enhancing user engagement and quality of life in individuals with Alzheimer's disease and related dementias.